E Merck introduces Livogen Z with zinc sulphate

by Medindia Content Team on  August 9, 2001 at 4:35 PM Drug News
RSS Email Print This Page Comment bookmark
Font : A-A+

E Merck introduces Livogen Z with zinc sulphate
E Merck has launched Livogen Z, in the market with zinc sulphate.Livogen Z is one of the three versions of the trademark haematinic drug Livogen.Livogen was an old product of Glaxo India with Rs 3 crore revenue.Glaxo India Ltd has sold its Livogen brand to E Merck India Ltd.

According to a notification sent to the Bombay Stock Exchange (BSE), Glaxo India signed a memorandum of understanding with E Merck India, selling all the rights, title and interest in the registered trademark Livogen. This Mumbai based company, E Merck had purchased Livogen from Glaxo India Ltd for Rs 8 crore. The plain Livogen tablet as well as the Livogen Z tablet are available in the market.

E Merck had introduced the tonic version of Livogen Z even before the tablets. E Merck will have only one version of Livogen Z and it will contain zinc sulphate. Zinc decreases tubal defects in pregnant women.The launch of this drug was delayed, as E Merck had to take Karnataka Food and Drugs control Administration's permission to change the composition of the drug. E Merck is believed to have added zinc sulphate to Livogen Z as they felt it was unethical to sell otherwise.


Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Top Ten Selling Drugs Minerals: Not Just the Gold And Silver Foods High in Zinc 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

News Category

News Archive

Loading...